Although some of today’s most talented scientists harbored life-long goals of becoming researchers, most people found their paths overtime. Steve Yancey falls into that second group of people. Fond of biology, his original aspiration was medical or veterinary school, but during his graduate-level laboratory classes, he found the academic setting to be too limiting. Instead, he tried the private sector for a chance to discover more diversity in his work.
Eventually, this led to a career in drug development, based in North Carolina’s Research Triangle Park, where Yancey has been for 30 years. Today, he is vice president and medicine development leader at GlaxoSmithKline (GSK), working to advance solutions for patients with respiratory conditions, such as severe asthma and chronic obstructive pulmonary disease (COPD).